無料セミナー : 2018年11月27日『オンコロジーにおける遺伝子治療・CAR-T細胞療法』 DelveInsight Business Research LLP共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

特殊ジェネリック薬市場:タイプ別(注射剤、経口薬)、用途別(腫瘍、炎症疾患、多発性硬化症、C型肝炎)、エンドユース別、セグメント予測

Specialty Generics Market Analysis By Type (Injectables, Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C), By End-use, And Segment Forecasts, 2014 - 2025

発行 Grand View Research, Inc. 商品コード 572918
出版日 ページ情報 英文 101 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.91円で換算しております。
Back to Top
特殊ジェネリック薬市場:タイプ別(注射剤、経口薬)、用途別(腫瘍、炎症疾患、多発性硬化症、C型肝炎)、エンドユース別、セグメント予測 Specialty Generics Market Analysis By Type (Injectables, Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C), By End-use, And Segment Forecasts, 2014 - 2025
出版日: 2017年09月22日 ページ情報: 英文 101 Pages
概要

当レポートでは、世界の特殊ジェネリック薬市場について調査し、市場の現状と将来的見通し、タイプ別、用途別、エンドユース別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 動向および調査範囲

  • 市場セグメンテーションと範囲
  • 市場促進因子分析
  • 市場阻害因子分析
  • 優先される主な機会
  • SWOT分析
  • 業界分析
  • 市場地位分析

第4章 タイプ別予測と動向分析

  • 動向分析
  • 注射剤
  • 経口薬
  • その他

第5章 用途別予測と動向分析

  • 動向分析
  • 腫瘍
  • 炎症疾患
  • 多発性硬化症
  • C型肝炎
  • その他

第6章 エンドユース別予測と動向分析

  • 動向分析
  • 特殊薬局
  • 小売り薬局
  • 院内薬局

第7章 地域別予測と動向分析

  • 地域別市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合環境

  • 企業プロファイル
目次
Product Code: GVR-1-68038-629-5

The global specialty generics market is expected to reach USD 174.9 billion by 2025, according to a new report by Grand View Research, Inc. Rise in demand for low-cost generic specialty drugs is a major factor estimated to accelerate the market growth during the forecast period. Introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases is expected to showcase huge opportunities for the specialty generic drug manufacturers. According to U.S. FDA, generic drugs cost 80% to 85% lower as compared to branded drugs. One of the factors contributing to their affordable price is that they do not need to repeat expensive clinical trials, advertising, and promotional activities. Thus, low cost of generic specialty drugs is expected to accelerate the demand for these medicines.

Rise in number of off-patent specialty drugs is another major factor expected to support growth of the specialty generic drugs market. For instance, the patent for Gilenya, a blockbuster drug by Novartis, will expire in 2019. This drug led to USD 3.1 billion in sales in 2016 for Novartis, with 14% sales growth. In April 2017, Novartis failed to acquire patent extension for Gilenya till 2026 in the U.S. Federal Circuit. Such early patent expirations are expected to boost the entry of new generics.

Further Key Findings From the Report Suggest:

  • In 2016, injectables was the largest revenue-grossing segment in the market due to its high usage and efficacy in treatment of severe chronic diseases
  • The oncology segment accounted for the largest revenue share in 2016 and is expected to maintain its dominance during the forecast period due to worldwide rise in cancer prevalence
  • The specialty pharmacy was the largest revenue-generating segment in end use and is estimated to maintain its dominance during the forecast period. This is due to the fact that specialty pharmacies are dedicated to distribution of highlycomplex, costly, and high-touch medicine
  • North America dominated the total market in 2016 primarily due to the presence of highly developed healthcare infrastructure and local presence of large number of established pharmaceutical companies
  • The Asia Pacific market is estimated to grow at the highest growth rate during the forecast period. Rising prevalence of chronic diseases, developing healthcare infrastructure, and escalating disposable income in Asian countries, such as China and India, are major factors that can be attributed to the growth
  • Some of the major players are Teva Pharmaceuticals USA, Inc.; Mylan N.V.; Sandoz International GmbH; Akorn, Inc.; Mallinckrodt; Valeant Pharmaceuticals International, Inc.; Pfizer, Inc.; Endo Pharmaceuticals, Inc.; Apotex Corp.; Sun Pharmaceutical Industries Ltd.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Specialty Generics Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Rising number of off-patent specialty drugs
    • 3.2.2 Escalating demand for low cost generic specialty drugs
    • 3.2.3 Increasing prevalence of chronic diseases
    • 3.2.4 Increasing emphasis to cut down healthcare expenditures
  • 3.3 Market Restraint Analysis
    • 3.3.1 Rigorous regulatory governance in countries
    • 3.3.2 Delay in new drug launches
  • 3.4 Key Opportunities Prioritized
    • 3.4.1 Key opportunities prioritized, by type
  • 3.5 Specialty Generic Drugs - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's
  • 3.7 Specialty Generics Market: Market Position Analysis

Chapter 4 Specialty Generics Market: Type Estimates & Trend Analysis

  • 4.1 Specialty Generics Market: Type Movement Analysis
  • 4.2 Injectables
    • 4.2.1 Injectables market, 2014 - 2025 (USD Billion)
  • 4.3 Oral Drugs
    • 4.3.1 Oral drugs market, 2014 - 2025 (USD Billion)
  • 4.4 Others
    • 4.4.1 Others market, 2014 - 2025 (USD Billion)

Chapter 5 Specialty Generics Market: Application Estimates & Trend Analysis

  • 5.1 Specialty Generics Market: Application Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology market, 2014 - 2025 (USD Billion)
  • 5.3 Inflammatory Conditions
    • 5.3.1 Inflammatory conditions market, 2014 - 2025 (USD Billion)
  • 5.4 Multiple Sclerosis
    • 5.4.1 Multiple sclerosis market, 2014 - 2025 (USD Billion)
  • 5.5 Hepatitis C
    • 5.5.1 Hepatitis C market, 2014 - 2025 (USD Billion)
  • 5.6 Others
    • 5.6.1 Others market, 2014 - 2025 (USD Billion)

Chapter 6 Specialty Generics Market: End-use Estimates & Trend Analysis

  • 6.1 Specialty Generics Market: End Use Movement Analysis
  • 6.2 Specialty Pharmacy
    • 6.2.1 Specialty pharmacy market, 2014 - 2025 (USD Billion)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail pharmacy market, 2014 - 2025 (USD Billion)
  • 6.4 Hospital Pharmacy
    • 6.4.1 Hospital pharmacy market, 2014 - 2025 (USD Billion)

Chapter 7 Specialty Generics Market: Regional Estimates & Trend Analysis, by Type, Application, End-use

  • 7.1 Specialty Generics Market Share by Region, 2016 & 2025
  • 7.2 North America
    • 7.2.1 U.S.
      • 7.2.1.1 U.S. specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.2.1.2 U.S. specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.2.1.3 U.S. specialty generics market, by end use, 2014 - 2025 (USD Billion)
    • 7.2.2 Canada
      • 7.2.2.1 Canada specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.2.2.2 Canada specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.2.2.3 Canada specialty generics market, by end use, 2014 - 2025 (USD Billion)
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Germany specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.3.1.2 Germany specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.3.1.3 Germany specialty generics market, by end use, 2014 - 2025 (USD Billion)
    • 7.3.2 UK
      • 7.3.2.1 UK specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.3.2.2 UK specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.3.2.3 UK specialty generics market, by end use, 2014 - 2025 (USD Billion)
    • 7.3.3 France
      • 7.3.3.1 France specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.3.3.2 France specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.3.3.3 France specialty generics market, by end use, 2014 - 2025 (USD Billion)
    • 7.3.4 Italy
      • 7.3.4.1 Italy specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.3.4.2 Italy specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.3.4.3 Italy specialty generics market, by end use, 2014 - 2025 (USD Billion)
    • 7.3.5 Spain
      • 7.3.5.1 Spain specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.3.5.2 Spain specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.3.5.3 Spain specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • 7.4 Asia Pacific
    • 7.4.1 Japan
      • 7.4.1.1 Japan specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.4.1.2 Japan specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.4.1.3 Japan specialty generics market, by end-use, 2014 - 2025 (USD Billion)
    • 7.4.2 China
      • 7.4.2.1 China specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.4.2.2 China specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.4.2.3 China specialty generics market, by end-use, 2014 - 2025 (USD Billion)
    • 7.4.3 India
      • 7.4.3.1 India specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.4.3.2 India specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.4.3.3 India specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • 7.5 Latin America
    • 7.5.1 Brazil
      • 7.5.1.1 Brazil specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.5.1.2 Brazil specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.5.1.3 Brazil specialty generics market, by end-use, 2014 - 2025 (USD Billion)
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.5.2.2 Mexico specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.5.2.3 Mexico specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • 7.6 MEA
    • 7.6.1 South Africa
      • 7.6.1.1 South Africa specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.6.1.2 South Africa specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.6.1.3 South Africa specialty generics market, by end-use, 2014 - 2025 (USD Billion)
    • 7.6.2 Saudi Arabia
      • 7.6.2.1 Saudi Arabia specialty generics market, by type, 2014 - 2025 (USD Billion)
      • 7.6.2.2 Saudi Arabia specialty generics market, by application, 2014 - 2025 (USD Billion)
      • 7.6.2.3 Saudi Arabia specialty generics market, by end-use, 2014 - 2025 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Teva Pharmaceuticals USA, Inc.
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Mylan N.V.
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Sandoz International GmbH
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Akorn, Inc.
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
    • 8.1.5 Mallinckrodt
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
    • 8.1.6 Valeant Pharmaceuticals International, Inc.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 Pfizer Inc.
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Endo Pharmaceuticals Inc.
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Apotex Corp.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Product Benchmarking
    • 8.1.10 Sun Pharmaceutical Industries Ltd.
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • TABLE 1 Factors used in segment share estimation
  • TABLE 2 List of secondary data sources
  • TABLE 3 North America specialty generics market, by country, 2014 - 2025 (USD Billion)
  • TABLE 4 North America specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 5 North America specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 6 North America specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 8 U.S. specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 9 U.S. specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 11 Canada specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 12 Canada specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe specialty generics market, by country, 2014 - 2025 (USD Billion)
  • TABLE 14 Europe specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 16 Europe specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 17 Europe specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 18 Germany specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 19 Germany specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 20 Germany specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 21 UK specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 22 UK specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 23 UK specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 24 France specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 25 France specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 26 France specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 27 Italy specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 28 Italy specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 29 Italy specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 30 Spain specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 31 Spain specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 32 Spain specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 33 Asia Pacific specialty generics market, by country, 2014 - 2025 (USD Billion)
  • TABLE 34 Asia Pacific specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 35 Asia Pacific specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 36 Asia Pacific specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 37 Japan specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 38 Japan specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 39 Japan specialty generics market, by end use, 2014 - 2025 (USD Billion)
  • TABLE 40 China specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 41 China specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 42 China specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 43 India specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 44 India specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 45 India specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 46 Latin America specialty generics market, by country, 2014 - 2025 (USD Billion)
  • TABLE 47 Latin America specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 48 Latin America specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 49 Latin America specialty generics market, by end use, 2014 - 2025 (USD Billion)
  • TABLE 50 Brazil specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 51 Brazil specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 52 Brazil specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 53 Mexico specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 54 Mexico specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 55 Mexico specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 56 MEA specialty generics market, by country, 2014 - 2025 (USD Billion)
  • TABLE 57 MEA specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 58 MEA specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 59 MEA specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 60 South Africa specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 61 South Africa specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 62 South Africa specialty generics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 63 Saudi Arabia specialty generics market, by type, 2014 - 2025 (USD Billion)
  • TABLE 64 Saudi Arabia specialty generics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 65 Saudi Arabia specialty generics market, by end-use, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Primary interviews, by sources
  • FIG. 2 Primary interviews, by region
  • FIG. 3 Market summary
  • FIG. 4 Market trends & outlook
  • FIG. 5 Market segmentation & scope
  • FIG. 6 Market driver relevance analysis (Current & future impact)
  • FIG. 7 Market restraint relevance analysis (Current & future impact)
  • FIG. 8 Regulatory Guidelines For Generic Medicines
  • FIG. 9 Key opportunities prioritized, by type
  • FIG. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 11 Porter's Five Forces Analysis
  • FIG. 12 Company market position analysis, 2016
  • FIG. 13 Specialty generics market, type outlook: Key takeaways
  • FIG. 14 Specialty generics market: Type movement analysis
  • FIG. 15 Injectables market, 2014 - 2025 (USD Billion)
  • FIG. 16 Oral drugs market, 2014 - 2025 (USD Billion)
  • FIG. 17 Others market, 2014 - 2025 (USD Billion)
  • FIG. 18 Specialty generics market, application outlook: Key takeaways
  • FIG. 19 Specialty generics market: Application movement analysis
  • FIG. 20 Oncology market, 2014 - 2025 (USD Billion)
  • FIG. 21 Inflammatory conditions market, 2014 - 2025 (USD Billion)
  • FIG. 22 Multiple sclerosis market, 2014 - 2025 (USD Billion)
  • FIG. 23 Hepatitis C market, 2014 - 2025 (USD Billion)
  • FIG. 24 Others market, 2014 - 2025 (USD Billion)
  • FIG. 25 Specialty generics market, end use outlook: Key takeaways
  • FIG. 26 Specialty generics market: End use movement analysis
  • FIG. 27 Specialty pharmacy market, 2014 - 2025 (USD Billion)
  • FIG. 28 Retail pharmacy market, 2014 - 2025 (USD Billion)
  • FIG. 29 Hospital pharmacy market, 2014 - 2025 (USD Billion)
  • FIG. 30 Regional market place: Key takeaways
  • FIG. 31 Regional outlook, 2016 & 2025
Back to Top